Trial intelligence / Profile preview

BACLOPHONE Cohort Study

NCT02596763Phase 4Terminated

Sponsor
CHU de Lille
Start
Dec 2015
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of baclofen in alcohol use disorder (AUD), sponsored by CHU de Lille. Started Dec 2015; status: terminated.

02

Drugs

baclofen
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT02596763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02596763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call